Anxiety disorders

Global Social Anxiety Disorder Market 2020 - Epidemiology Analysis by Country

Retrieved on: 
Monday, June 8, 2020
Psychiatry, Anxiety disorders, Psychiatric diagnosis, Psychology, Human behavior, RTT, Abnormal psychology, Social anxiety disorder, Anxiety, Social anxiety, Generalized anxiety disorder, Anxiolytic

DUBLIN, June 8, 2020 /PRNewswire/ -- The "Global Social Anxiety Disorder Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, June 8, 2020 /PRNewswire/ -- The "Global Social Anxiety Disorder Market and Competitive Landscape - 2020" report has been added to ResearchAndMarkets.com's offering.
  • This report provides comprehensive insights into the Social Anxiety Disorder pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research covers the following: Social Anxiety Disorder treatment options, Social Anxiety Disorder late stage clinical trials pipeline, Social Anxiety Disorder prevalence by countries, Social Anxiety Disorder market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.
  • Social Anxiety Disorder pipeline: Find out drugs in clinical trials for the treatment of Social Anxiety Disorder by development phase 3, phase 2, and phase 1, by pharmacological class and company
    Social Anxiety Disorder drugs: Identify key drugs marketed and prescribed for Social Anxiety Disorder in the US, including trade name, molecule name, and company
    Social Anxiety Disorder drugs sales: Find out the sales value for Social Anxiety Disorder drugs by countries
    Social Anxiety Disorder market valuations: Find out the market size for Social Anxiety Disorder drugs in 2019 by countries.

COVID-19 Impact and Recovery Analysis | Global Alprazolam Market 2020-2024 | Evolving Opportunities with Amneal Pharmaceuticals Inc. and Cadila Healthcare Ltd. | Technavio

Retrieved on: 
Wednesday, June 3, 2020
Biotechnology, Pharmaceutical, Health, Mental health, Psychiatry, RTT, Psychiatric diagnosis, Psychology, Anxiety disorders, Human behavior, Abnormal psychology, GABAA receptor positive allosteric modulators, Alprazolam, Anxiety, Panic disorder, Generalized anxiety disorder

The market is driven by the increasing prevalence of anxiety disorders.

Key Points: 
  • The market is driven by the increasing prevalence of anxiety disorders.
  • In addition, the use of alprazolam in new research areas is anticipated to boost the growth of the alprazolam market.
  • The middle-aged and older population are more likely to experience psychiatric indications such as anxiety and panic disorders.
  • In addition, the prevalence of anxiety and panic disorders is also on the rise among the younger population due to hectic lifestyles.

Fourth-Annual Pet Anxiety Awareness Campaign Kicks Off on June 1

Retrieved on: 
Wednesday, May 27, 2020
Chemical substances, Chemistry, Materials, Anxiety, Emotions, Psychiatric diagnosis, Anxiety disorders, Pet, Bark, Separation anxiety disorder, Polyethylene terephthalate

TAMPA, Fla., May 27, 2020 /PRNewswire/ -- Pet Living with Kristen Levine , an online pet parenting guide for pet parents, announced that the fourth-annual Pet Anxiety Awareness campaign (PAAW) will be observed from June 1st through June 30th.

Key Points: 
  • TAMPA, Fla., May 27, 2020 /PRNewswire/ -- Pet Living with Kristen Levine , an online pet parenting guide for pet parents, announced that the fourth-annual Pet Anxiety Awareness campaign (PAAW) will be observed from June 1st through June 30th.
  • Through years of research with some of the world's top pet experts, special content was created by DOGTV to help reduce stress, separation anxiety or other related problems.
  • They proudly support each pet parent in their goal to improve the life of their pet and their entire family.
  • ThunderShirt is proven to be over 80% effective in reducing anxiety for loud noises, separation anxiety, travel, vet visits, and problem barking.

Lief Therapeutics Announces Downtime™ Digital Anxiety Treatment Now Available Under FDA's COVID-19 Emergency Guidance

Retrieved on: 
Wednesday, May 6, 2020
Psychiatry, Anxiety disorders, Psychiatric diagnosis, Psychology, Medical diagnosis, RTT, Abnormal psychology, Anxiety, Social anxiety disorder, Generalized anxiety disorder, Posttraumatic stress disorder, Social anxiety

SAN FRANCISCO, May 6, 2020 /PRNewswire-PRWeb/ --Lief Therapeutics today announced its Downtime digital anxiety intervention is available as an adjunct treatment for Generalized Anxiety Disorder during the COVID-19 emergency.

Key Points: 
  • SAN FRANCISCO, May 6, 2020 /PRNewswire-PRWeb/ --Lief Therapeutics today announced its Downtime digital anxiety intervention is available as an adjunct treatment for Generalized Anxiety Disorder during the COVID-19 emergency.
  • For the duration of the COVID-19 emergency, physicians can prescribe Downtime to help patients manage symptoms of anxiety in conjunction with their primary treatment plan.
  • A meta-analysis of 2,086 anxiety patients found that low HRV is associated with anxiety disorders, including generalized anxiety disorder, social anxiety, PTSD, and panic.
  • Lief Rx, Lief's prescription-only device for patients, can be used as an adjunct treatment for generalized anxiety disorder after consultation with a physician.

In Times of Uncertainty, ChildCare Education Institute Offers a Free Course to All Users on Coping with Crises and Traumatic Events

Retrieved on: 
Friday, May 1, 2020
Articles, Stress, Humans, Human behavior, Interpersonal conflict, Anxiety disorders, Adverse childhood experiences, Coping, Psychological trauma, Child care

ChildCare Aware of America reports that there are nearly 11 million children under the age of five in child care each week.

Key Points: 
  • ChildCare Aware of America reports that there are nearly 11 million children under the age of five in child care each week.
  • This is especially important because children may not be mobile or able to communicate basic information to a rescuer.
  • The actions your program takes to offer relief can reduce the stress and enable individuals to rebuild their lives.
  • ADM107: Coping With Crises and Traumatic Events is a three-hour, beginner-level course and grants 0.3 IACET CEU upon successful completion.

VistaGen Expands PH94B Clinical Development to Include Adjustment Disorder Related to COVID-19

Retrieved on: 
Tuesday, April 28, 2020
Psychiatry, Psychiatric diagnosis, Anxiety disorders, RTT, Medical diagnosis, Psychology, Abnormal psychology, Social anxiety disorder, Sertraline

The FDA previously designated PH94B for Fast Track development for treatment of social anxiety disorder (SAD), the first such designation by the FDA for a drug candidate for SAD.

Key Points: 
  • The FDA previously designated PH94B for Fast Track development for treatment of social anxiety disorder (SAD), the first such designation by the FDA for a drug candidate for SAD.
  • VistaGen is currently preparing for Phase 3 development of PH94B for treatment of SAD.
  • Dr. Michael Liebowitz, a member of VistaGen's CNS Clinical and Regulatory Advisory Board, will serve as Principal Investigator of the Phase 2 Part A study of PH94B for treatment of adjustment disorder.
  • Following successful Phase 2 development, VistaGen is preparing for Phase 3 clinical development of PH94B for SAD and Phase 2 development for adjustment disorder.

AllenComm Partners with Columbia University Psychiatric Department to Offer Free Online Guide to Overcome Anxiety Caused by COVID-19

Retrieved on: 
Thursday, March 26, 2020
Anxiety, Emotions, Psychology, Anxiety disorders, Psychiatric diagnosis, Human behavior

SALT LAKE CITY, March 26, 2020 /PRNewswire-PRWeb/ --AllenComm partnered with the Columbia University Department of Psychiatry to create a free online guide, to combat feelings of anxiety and the resulting uncertainty from the recent outbreak of COVID-19.

Key Points: 
  • SALT LAKE CITY, March 26, 2020 /PRNewswire-PRWeb/ --AllenComm partnered with the Columbia University Department of Psychiatry to create a free online guide, to combat feelings of anxiety and the resulting uncertainty from the recent outbreak of COVID-19.
  • COVID-19: 5 Tips to Face Your Anxiety is a free digital guide designed by AllenComm and written by Dr. Anne Marie Albano, author, and Founder of the Columbia University Clinic for Anxiety and Related Disorders.
  • This is a free resource designed to help those that feel anxiety and panic from the resulting uncertainty caused by the outbreak.
  • "Our goal is to give practical information on how to think through, calm yourself, and manage during this COVID-19 pandemic.

Leading Telehealth Counseling Provider, Lionrock, Launches Free COVID-19 Anxiety Support Meetings via Video Conference

Retrieved on: 
Thursday, March 19, 2020
Mental health, Health, Articles, Health informatics, Technology, Anxiety, Emotions, Telehealth, eHealth, Psychotherapy, Anxiety disorders

Lionrock Recovery, the leader in telehealth services for substance use disorders, today announced the launch of its free COVID-19 Anxiety Support Meetings.

Key Points: 
  • Lionrock Recovery, the leader in telehealth services for substance use disorders, today announced the launch of its free COVID-19 Anxiety Support Meetings.
  • Similar to Lionrock therapy sessions, the COVID-19 Anxiety Support Meetings will be held via secure video conference, allowing participants to join from the privacy of home.
  • Weve heard from hundreds of our own clients, as well as colleagues, friends and family, that theyre struggling with anxiety about the COVID-19 pandemic.
  • Lionrocks COVID-19 Anxiety Support Meeting sessions will be an hour long, held multiple times a week and accessible for free internationally.

Oxford VR Launch Social Engagement™ - a First-in-class Digital Therapeutic Using Virtual Reality Technology to Tackle Anxious Social Avoidance

Retrieved on: 
Tuesday, March 10, 2020
Psychiatry, Abnormal psychology, Human behavior, Virtual reality, Anxiety disorders, Phobias, New media, Psychopathology, Behaviour therapy, Cognitive behavioral therapy, Social anxiety disorder, Immersion

OXFORD, England, March 10, 2020 /PRNewswire/ -- Oxford VR (OVR) announces the launch of OVR social engagementa ground-breaking and progressivebehavioral health intervention using virtual reality technology to help individuals overcome anxious social avoidance, prevalent in multiple mental health conditionsincludingagoraphobia, panic disorder, social anxiety, depression, personality disorders, and schizophrenia.

Key Points: 
  • OXFORD, England, March 10, 2020 /PRNewswire/ -- Oxford VR (OVR) announces the launch of OVR social engagementa ground-breaking and progressivebehavioral health intervention using virtual reality technology to help individuals overcome anxious social avoidance, prevalent in multiple mental health conditionsincludingagoraphobia, panic disorder, social anxiety, depression, personality disorders, and schizophrenia.
  • Founded in 2017, Oxford VR's work is at the frontiers of exciting innovation in behavioral healthcare using powerful virtual reality technology and evidence-based science to improve capacity and outcomes.
  • In severe and complex mental health conditions such as schizophrenia, anxious social avoidance leading to isolation is frequently seen.
  • [3]
    Developed by OVR clinicians, OVR social engagement is a user-centred program that translates evidence-based cognitive-behavioural therapy (CBT) through immersive virtual reality environments.

Researchers Say Extended Antidepressant Use Creates Physical Dependence

Retrieved on: 
Thursday, February 20, 2020
Psychiatric diagnosis, Psychiatry, RTT, Depression, Medical diagnosis, Medicine, Withdrawal syndromes, Anxiety disorders, Antidepressant, Major depressive disorder, Substance dependence, Suicidal ideation

However, researchers say they will likely face difficult and even dangerous withdrawal symptoms due to a physical dependence.

Key Points: 
  • However, researchers say they will likely face difficult and even dangerous withdrawal symptoms due to a physical dependence.
  • The best process is to follow a tapering schedule while consulting with a physician, according to research in The Journal of the American Osteopathic Association.
  • "I understand that many people feel safe in that their depression or anxiety is continuously managed by medication.
  • Discontinuing any antidepressant also carries a risk for gradual worsening or relapsing of depression and anxiety, as well as suicidal thoughts.